Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

Publisher: John Wiley & Sons Inc

E-ISSN: 1463-1326|20|2|453-457

ISSN: 1462-8902

Source: DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.20, Iss.2, 2018-02, pp. : 453-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content